Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors

Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors

Diabetes mellitus is associated with poor outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Diabetic ketoacidosis (DKA) has also been reported to occur with this virus. A cluster of cases of euglycemic DKA (euDKA) was identified in patients with type 2 diabetes mell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AACE clinical case reports 2021-01, Vol.7 (1), p.10-13
Hauptverfasser: Vitale, Rebecca J., Valtis, Yannis K., McDonnell, Marie E., Palermo, Nadine E., Fisher, Naomi D.L.
Format: Artikel
Sprache:eng
Schlagworte:
Case Report
COVID-19
diabetic ketoacidosis
sodium-glucose cotransporter-2 inhibitors
type 2 diabetes mellitus
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Diabetes mellitus is associated with poor outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Diabetic ketoacidosis (DKA) has also been reported to occur with this virus. A cluster of cases of euglycemic DKA (euDKA) was identified in patients with type 2 diabetes mellitus using sodium-glucose cotransporter-2 inhibitors (SGLT2is) who developed SARS-CoV-2 infection. The cases were identified by the authors while providing clinical care, and details were collected. Five cases of euDKA, presenting with glucose levels
ISSN:2376-0605
2376-0605
DOI:10.1016/j.aace.2020.11.019